Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Piero Anversa retractions trigger trial pause

This week in cell therapy: Orchard Therapeutics closes US$225 million IPO and vision restored in blind rats following fetal cell transplant.

Go to the profile of RegMedNet
Nov 08, 2018
0
0

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.

Register

No comments yet.